Grant List
Represents Grant table in the DB
GET /v1/grants?page%5Bnumber%5D=1392&sort=-title
{ "links": { "first": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1&sort=-title", "last": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1405&sort=-title", "next": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1393&sort=-title", "prev": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1391&sort=-title" }, "data": [ { "type": "Grant", "id": "11899", "attributes": { "award_id": "1R13AI176856-01", "title": "2023 Salmonella Biology and Pathogenesis Gordon Research Conference and Seminar", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 22573, "first_name": "Barbara L.", "last_name": "Mulach", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-07-11", "end_date": "2023-11-30", "award_amount": 6500, "principal_investigator": { "id": 27798, "first_name": "Renee M", "last_name": "Tsolis", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "The Gordon Research Conference (GRC) on Salmonella Biology and Pathogenesis is an international scientific conference that brings together researchers with a shared interest in understanding the fundamental biology, pathogenesis, and immune response to Salmonella serovars. This meeting is a longstanding conference, that was originally held under the auspices of the American Society of Microbiology; the 2023 conference (rescheduled from 2021 due to the COVID-19 pandemic) will be the second GRC, and will be held at the Renaissance Tuscany Il Ciocco (Italy), a well-established site for the GRC organization. The 2023 meeting will be held July 23-28 and will have an associated Gordon Research Seminar to (i) provide students and postdocs a basic background in the concepts, principles, and mechanisms involved in different areas of Salmonella biology and pathogenesis; (ii) promote the interaction of junior investigators with their peers and selected senior members of the field (keynote speaker and discussion leaders); (iii) provide feedback on their research, thereby sharpening their presentation skills and the sophistication of their discussions in preparation for the main meeting and beyond. There is a need for a conference dedicated to the biology of Salmonella infections, because Salmonella is studied not only as an important cause of disease, but its well-characterized biology, genetics and infection models have made it the pathogen of choice to interrogate many fundamental aspects of biology, including innate and adaptive immunity, post-transcriptional gene regulation, and the function of the gut microbiota. The GRC will encompass a broad range of topics, from epidemiology and vaccines to cell biology and gene regulation. Attendees will include an equal distribution of independent investigators, post-doctoral scholars, and graduate students. There will be nine seminar sessions with session leaders that will provide an overview of the topic and stimulate discussion from the attendees. The 2023 meeting will be organized by Chairs Renée Tsolis (University of California, Davis) and Michael Hensel (University of Braunschweig, Germany) and the vice-chairs Leigh Knodler (Washington State University) and Dirk Bumann (Biozentrum, Basel, Switzerland). This meeting provides a forum where cutting edge research will be presented. There are slots reserved in thematic seminar sessions for presentations by postdoctoral fellows and graduate students, giving them an opportunity to share their discoveries and gain exposure. The inaugural GRS of this conference will be co-chaired by Lizbeth Camacho (University of California, Davis) and Joshua Newson (ETH, Zürich, Switzerland). This meeting provides an environment that enables networking and collaboration among investigators and gives post- doctoral researchers and graduate students access to leaders in Salmonella biology and related fields. The program includes new investigators that have not previously presented their research at this meeting, and includes sessions that reflect the emerging importance of antibiotic-resistant Salmonella and novel strategies to overcome antibiotic resistance.", "keywords": [ "Address", "American", "Antibiotic Resistance", "Area", "Biology", "COVID-19 pandemic", "California", "Cellular biology", "Cessation of life", "Collaborations", "Communicable Diseases", "Dedications", "Disease", "Ensure", "Environment", "Epidemiology", "Feedback", "Fees", "Funding", "Future", "Gender", "Gene Expression Regulation", "Genetic", "Germany", "Goals", "Human", "Immune response", "Immunology", "Incentives", "Infection", "International", "Italy", "Knowledge", "Mentors", "Microbiology", "Minority", "Mission", "Modeling", "National Institute of Allergy and Infectious Disease", "Natural Immunity", "Participant", "Pathogenesis", "Post-Transcriptional Regulation", "Postdoctoral Fellow", "Preparation", "Renaissance", "Research", "Research Personnel", "Salmonella", "Salmonella infections", "Schedule", "Scientist", "Senior Scientist", "Site", "Societies", "Students", "Switzerland", "Time", "Training", "Travel", "Universities", "Vaccines", "Voting", "Washington", "Woman", "adaptive immunity", "frontier", "graduate student", "gut microbiota", "interest", "meetings", "member", "microbial", "next generation", "novel strategies", "pathogen", "peer", "preference", "prevent", "programs", "skills", "success", "symposium" ], "approved": true } }, { "type": "Grant", "id": "10824", "attributes": { "award_id": "1R13DE032539-01", "title": "2023 Salivary Glands and Exocrine Biology GRC and GRS", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Dental and Craniofacial Research (NIDCR)" ], "program_reference_codes": [], "program_officials": [ { "id": 26333, "first_name": "Amanda A", "last_name": "Melillo", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-01-01", "end_date": "2023-12-31", "award_amount": 15000, "principal_investigator": { "id": 26909, "first_name": "Olga Juliana", "last_name": "Baker", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "This proposal requests partial support for the thirteenth Gordon Research Conference (GRC) and the third Gordon Research Seminar (GRS) entitled Salivary Glands and Exocrine Biology: Understanding the Biology of Secretory Function and Diseases of Exocrine Tissues to be held from Back January 29th-February 3rd, 2023, at the Four Points Sheraton hotel in Ventura, CA. The GRC will include plenary sessions on exocrine gland development, regenerative approaches, functional relevance of salivary proteins, membrane functions in exocrine glands, understanding the etiology of autoimmune disease, targeting inflammation to retard disease pathogenesis and current topics in exocrine gland:pathogen such as SARS-CoV2 interactions. Invited speakers for the GRC will include eminent scientists from academia, industry and government and talks will include both senior and junior scientists from diverse fields who will present current unpublished research findings on subjects identified by previous meeting organizers and attendees as of greatest interest to the field. Several keynote speakers will be invited to deliver seminars on stem cell therapeutics, clinical genomics and clinical trials for Sjögren's disease, a common autoimmune disease that affects exocrine glands and negatively impacts the quality of life of patients for whom no suitable and effective therapies are available. A noteworthy feature of this GRC will be continuation of a GRS to be held just prior to the GRC, first offered in 2017, that will invite only speakers who are graduate students and postdoctoral associates in a wide variety of laboratories worldwide. These junior scientists at the GRS will also attend the GRC where many of them will be chosen to give seminars that will be included in the plenary sessions. In addition, poster sessions will be held daily at the GRC to enable all attendees to present and discuss their data in an open forum. The overall goal of the GRC and GRS will be to foster scientific exchanges and engender research collaborations in disciplines that are viewed as having a major impact on the development of novel strategies to improve human health. Specific Aims in line with the NIDCR mission include: 1) to present a program of topical interest to scientists in academia, industry and government and to assemble junior and senior investigators in a pleasant setting where they will have opportunities to discuss unpublished findings before a knowledgeable audience and engage in a wide range of critical research discussions; 2) to offer a GRS to be attended by graduate students and postdoctoral associates who will present their novel research findings before an audience of their peers and; 3) to emphasize presentations on state-of-the-art methodologies of interest to the exocrine biology field towards the goal of developing innovative approaches to the improvement of human health by preventing disorders of secretory organs.", "keywords": [ "2019-nCoV", "Academia", "Affect", "Autoimmune Diseases", "Back", "Basic Science", "Biology", "Clinic", "Clinical", "Clinical Trials", "Collaborations", "Data", "Dental", "Development", "Developmental Biology", "Discipline", "Disease", "Emerging Technologies", "Environment", "Etiology", "Evaluation", "Exocrine Glands", "Fostering", "Genetic", "Genomics", "Glycobiology", "Goals", "Government", "Government Agencies", "Health", "Hearing", "Human", "Immune system", "Industry", "Inflammation", "Institution", "International", "Laboratories", "Lacrimal gland structure", "Learning Skill", "Lung", "Mammary gland", "Membrane", "Mentors", "Methodology", "Mission", "National Institute of Dental and Craniofacial Research", "Natural regeneration", "Oral", "Organ", "Pancreas", "Participant", "Pathogenesis", "Patients", "Postdoctoral Fellow", "Quality of life", "Request for Proposals", "Research", "Research Personnel", "Research Training", "Resolution", "Salivary Glands", "Salivary Proteins", "Scientist", "Secretory Cell", "Sjogren&apos", "s Syndrome", "Stress", "Sweat Glands", "Systems Biology", "Tissues", "Virus Diseases", "Work", "Writing", "career", "craniofacial", "effective therapy", "gland development", "graduate student", "improved", "innovation", "interest", "metabolomics", "novel", "novel strategies", "pathogen", "peer", "posters", "prevent", "programs", "regenerative approach", "saliva secretion", "stem cell therapy", "stem cells", "symposium", "tissue degeneration", "tissue regeneration", "tissue repair", "translational applications", "undergraduate student", "unpublished works" ], "approved": true } }, { "type": "Grant", "id": "10838", "attributes": { "award_id": "1R13CA277856-01", "title": "2023 RNA Nanotechnology Gordon Research Conference and Seminar", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Cancer Institute (NCI)", "National Center for Advancing Translational Sciences (NCATS)" ], "program_reference_codes": [], "program_officials": [ { "id": 23177, "first_name": "Yvonne", "last_name": "Duglas Tabor", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-01-13", "end_date": "2023-12-31", "award_amount": 10000, "principal_investigator": { "id": 23572, "first_name": "LOUISE CHANG", "last_name": "LAURENT", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "This R13 application requests partial funding to support the upcoming Gordon Research Conference (GRC) on RNA Nanotechnology, which will be held in Ventura, CA on Jan 8-13, 2023, and the associated Gordon Research Symposium (GRS), to precede it on Jan 7-8. The meeting will be co-chaired by Louise Laurent and Sarah Woodson, who were elected at the second GRC on RNA Nanotechnology in January 2017 and served as the co-vice chairs of the third GRC in January 2019. The conference planned for 2021 was postponed by the GRC due to the COVID pandemic. RNA nanotechnology continues to grow as an important field, with active research being carried out to elucidate basic principles of and develop innovative approaches to the design and construction of a variety of RNA nanostructures, as well as exciting work applying RNA nanotechnology to solving problems in biotechnology and medicine. The pace of discovery and innovation has only accelerated in the past two years. RNA nanotechnology is built upon unique properties of RNA, including structural versatility, existing biological functions, and ease of functionalization, which make it an ideal platform on which to build complex self-assembling architectures with a variety of functional attributes for diverse applications. This GRC focuses on linking fundamental studies on the mechanisms of RNA structure, assembly, and packaging to translational work using RNA nanotechnology in imaging, diagnostics, and therapeutics. The meeting will cover a range of topics in nine sessions. Sessions on RNA Modifications & Biotypes, RNA Structure & Assembly, and Synthetic & Programmed Nucleic Acid Assemblies will feature cutting-edge research on the molecular basis of nucleic acid architectures, design and characterization of nucleic acid nanostructures, and biophysical approaches to study and predict RNA folding. Emerging new applications of nucleic acid architectures as functional devices and as control elements in synthetic biology will be presented in sessions on RNA Aptamers & Riboswitches and RNA Imaging. Sessions on RNA Encapsulation & Delivery, RNA Cargo Selection in extracellular vesicles, RNA-based Biomarkers & Diagnostics, and RNA Therapeutics will provide perspectives on discovery, isolation and application of RNA from extracellular vesicles and viruses with an emphasis on translational aspects of natural and synthetic RNAs in development of diagnostics and therapeutics. The 2023 conference will continue to emphasize robust representation of women and minority scientists. The invited speakers and discussion leaders will include a mix of established researchers in the field and outstanding junior-level investigators from around the world. The meeting will be advertised to a diverse audience to include early career and under-represented minority scientists in the RNA nanotechnology and related fields. A Power Hour will feature topics of inclusion and opportunity.", "keywords": [ "Academia", "Acceleration", "Address", "Advertisements", "Advertising", "Architecture", "Area", "Base Pairing", "Biological Assay", "Biological Markers", "Biological Process", "Biological Response Modifier Therapy", "Biology", "Biophysics", "Biotechnology", "COVID-19 pandemic", "Characteristics", "Chemicals", "Chemistry", "Collaborations", "Collection", "Communication", "Communities", "Complex", "Computational Biology", "Dedications", "Development", "Devices", "Diagnosis", "Diagnostic", "Disease", "Drug Industry", "Early Diagnosis", "Elements", "Encapsulated", "Engineering", "Ensure", "Environment", "Feedback", "Free Energy", "Funding", "Future", "Genetic Transcription", "Genome", "Government", "Growth", "Hour", "Image", "Knowledge", "Link", "Medicine", "Modification", "Molecular", "Nanostructures", "Nanotechnology", "Nucleic Acids", "Participant", "Postdoctoral Fellow", "Principal Investigator", "Problem Solving", "Productivity", "Property", "Proteins", "RNA", "RNA Folding", "RNA chemical synthesis", "RNA vaccine", "Reporting", "Request for Applications", "Research", "Research Activity", "Research Personnel", "Role", "Schedule", "Scientist", "Structure", "Technology", "Therapeutic", "Time", "Translating", "Underrepresented Minority", "Untranslated RNA", "Vaccines", "Vertebral column", "Virus", "Woman", "Work", "aptamer", "base", "biophysical techniques", "career", "clinical application", "clinical diagnostics", "coronavirus disease", "design", "design and construction", "drug development", "extracellular", "extracellular vesicles", "fundamental research", "graduate student", "innovation", "interdisciplinary collaboration", "interest", "metabolic engineering", "minority scientist", "nanocomplexes", "new growth", "novel", "novel therapeutics", "programs", "rational design", "screening", "self assembly", "success", "supportive environment", "symposium", "synthetic biology", "therapeutic RNA", "translational applications", "translational approach", "translational potential", "undergraduate student" ], "approved": true } }, { "type": "Grant", "id": "10776", "attributes": { "award_id": "1R13AI174388-01", "title": "2023 Physical Virology GRC and GRS", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 22573, "first_name": "Barbara L.", "last_name": "Mulach", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2022-12-12", "end_date": "2023-04-30", "award_amount": 6500, "principal_investigator": { "id": 26850, "first_name": "MICHAEL F", "last_name": "HAGAN", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "Viral infections involve processes from atomic-scale regulation of ionic transport, to macromolecular self- assembly and membrane budding, to global epidemiology. Physical Virology studies these processes as a paradigm for the intersection of fundamental physical laws and emergent biological function. This biennial GRC is the only international meeting for researchers from the diverse disciplines relevant to Physical Virology, and is unique for its simultaneous focus on fundamental and applied aspects of virology. The scientific objectives of this GRC are to (1) uncover the biophysical principles that govern viral lifecycles, (2) use this knowledge to advance development of vaccines, antiviral drugs, and engineering virus-based biomaterials, and (3) broaden physical virology to leverage recent advances in cell biology and protein design. The COVID-19 pandemic highlights the need for these cross-disciplinary approaches to understand viral biology, predict their global spread and impact, and develop new treatments. The 2023 Physical Virology GRC will be held January 22-27 in Il Ciocco, Italy with the accompanying Gordon Research Seminar (GRS) on January 21-22. Our conference goals are in-line with the missions of NIAID to support basic and applied research on causative agents of infectious diseases, and NIBIB to improve health by accelerating development of biomedical technologies. The Physical Virology GRC/GRS have three independent but synergistic Aims. Aim 1 will promote and broaden interdisciplinary research in Physical Virology. We have 29 invited speakers (27 confirmed) and nine discussion leaders (all confirmed) at the frontiers of physical virology. To foster cross-disciplinary collaboration, sessions include speakers from different disciplines focusing on common aspects of virology. The conference will expand physical virology by including recent advances in (1) understanding virus-host interactions (e.g. virus- host protein interaction networks and co-evolution of viruses and host immune systems), (2) assembly of virus- like cages in other systems, and (3) emerging knowledge on COVID-19. The program promotes collaboration and networking through informal discussion times and 4 poster sessions. Aim 2 will increase the diversity, equity, and inclusivity (DEI) of the Physical Virology community. Of our invited speakers and discussion leaders, 53% are women, 10% are URMs, and 34% are early-career researchers. We will amplify diversity when selecting short talks. At a Power Hour, participants will discuss how to address issues faced by underrepresented groups in science. Aim 3 will provide training and career development for early career researchers. Poster presentations will be accepted from all students and postdocs, and they will be given priority for selection of short talks from abstracts. The GRS is organized by a graduate student and postdoc for this target group. The (to be confirmed) GRS keynote speaker is Dr. Barney Graham, former Deputy Director of the Vaccine Research Center at NIAID.", "keywords": [ "2019-nCoV", "Academia", "Address", "Advanced Development", "Antiviral Agents", "Applied Research", "Asia", "Awareness", "Basic Science", "Biocompatible Materials", "Biological Process", "Biological Sciences", "Biology", "Biomedical Technology", "Biophysical Process", "Biophysics", "COVID-19", "COVID-19 pandemic", "COVID-19 vaccine", "Career Mobility", "Cellular biology", "Chemistry", "Clinical Trials", "Collaborations", "Communicable Diseases", "Communication", "Communities", "Computational Science", "Critiques", "Development", "Diagnostic", "Discipline", "Drug Delivery Systems", "Engineering", "Ensure", "Epidemic", "Epidemiology", "Ethnic Origin", "Evaluation", "Evolution", "Female", "Fostering", "Gender", "Genes", "Goals", "Health", "Hour", "Human", "Immune system", "Individual", "Industry", "Infectious Agent", "Institutes", "Interdisciplinary Communication", "Interdisciplinary Study", "International", "Italy", "Knowledge", "Laboratories", "Laws", "Link", "Mathematics", "Membrane", "Mentorship", "Mission", "National Institute of Allergy and Infectious Disease", "National Institute of Biomedical Imaging and Bioengineering", "Participant", "Physics", "Postdoctoral Fellow", "Prevention", "Process", "Protein Analysis", "Protein Engineering", "Proteins", "Race", "Regulation", "Research", "Research Personnel", "Role", "STEM field", "Science", "Scientist", "South America", "Students", "System", "Therapeutic", "Time", "Training", "Underrepresented Populations", "United States National Institutes of Health", "Vaccine Research", "Vaccines", "Viral", "Viral Pathogenesis", "Virus", "Virus Assembly", "Virus Diseases", "Woman", "Work", "base", "career", "career development", "design", "diversity and equity", "frontier", "graduate student", "improved", "insight", "male", "materials science", "meetings", "nanotechnology platform", "neutralizing monoclonal antibodies", "non-tenure faculty", "novel therapeutics", "novel vaccines", "physical science", "posters", "programs", "self assembly", "symposium", "trend", "vaccine candidate", "vaccine development", "virology", "virus host interaction" ], "approved": true } }, { "type": "Grant", "id": "11083", "attributes": { "award_id": "1R13AI176857-01", "title": "2023 Phagocytes Gordon Research Conference and Gordon Research Seminar", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 23719, "first_name": "Susan F.", "last_name": "Cooper", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-03-06", "end_date": "2024-02-29", "award_amount": 11000, "principal_investigator": { "id": 27055, "first_name": "Sergio Daniel", "last_name": "Catz", "orcid": null, "emails": "[email protected]", "private_emails": null, "keywords": "[]", "approved": true, "websites": "[]", "desired_collaboration": "", "comments": "", "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "The Phagocyte Gordon Conference (GRC) and associated Gordon Research Seminar (GRS) will be held June 3-9, 2023 at Waterville Valley, NH. This will be the 22nd iteration of this GRC. Phagocytes are cells that have the capacity to engulf other cells or particles. Phagocytes include cells of the immune system such as neutrophils, monocytes/macrophages, and dendritic cells, analogous cell types in flies and worms, “nonclassical” phagocytes like microglia, and single-celled amoeba. While phagocytes are central to immunity, they also play roles in tissue homeostasis and development. When dysregulated, phagocytes contribute to prominent pathologies including atherosclerosis, diabetes, cancer, autoimmunity, and infectious diseases. The theme of the 2023 Phagocytes GRC is “Molecular and Cellular Diversity in Host Defense and Inflammation.” It will be the premier forum for sharing the most recent unpublished discoveries in phagocyte biology. Featured topics include phagocyte differentiation and plasticity, mechanisms of migration and phagocytosis, autophagy and cell death mechanisms, microglia and neuroinflammation, phagocytes in cancer, host-pathogen interactions, phagocyte crosstalk, interaction with the microbiota, and technological innovations in phagocyte biology. Novel translational approaches for phagocytes in different diseases will also be covered. Attendees are leading international scientists in cell biology, molecular genetics, microbiology, immunology, bioengineering, and clinical medicine. The average attendance is 148 attendees. In 2022 (postponed from 2021 due to COVID-19), 52.3% of attendees were women and 55.4% were graduate students or postdocs. The 2023 Phagocytes GRC features 13 female and 11 male invited speakers (54.2% female), with one keynote speaker, who will present their exciting unpublished findings. 37.5% of speakers identify as URM. Nine sessions will be chaired by discussion leaders who are experts in the field. As in past GRCs, 16 early-career scientists (graduate students, postdocs, assistant professors) will be selected for short talks based on submitted abstracts, and another 16 will give a brief preview of their poster. Approximately 120 posters will be presented in sessions that do not overlap with the talks. To enhance the participation and professional development of students and postdocs, a GRS will take place immediately prior to the start of the GRC (June 3-4). Organized and chaired by trainees, the GRS is an inclusive environment for the next generation of phagocyte scientists to share their research and build community. A comprehensive Diversity Plan will ensure that attendees and presenters are from diverse backgrounds and the conference environment is inclusive and equitable. The 2023 Phagocytes GRC and GRS will serve as a nexus for sharing cutting-edge unpublished research in phagocyte biology, thereby facilitating communication and collaboration between investigators studying different aspects of phagocytes, providing an inclusive and supportive environment for trainees and young investigators to network, and ultimately identifying translational and therapeutic targets of phagocytes in human health.", "keywords": [ "Adaptive Immune System", "Address", "Advocate", "Alzheimer&apos", "s Disease", "Amoeba genus", "Area", "Atherosclerosis", "Atmosphere", "Autoimmune Diseases", "Autoimmunity", "Autophagocytosis", "Biochemistry", "Biology", "Biomedical Engineering", "Brain", "COVID-19", "Cardiovascular Diseases", "Cell Death", "Cells", "Cellular biology", "Clinical", "Clinical Medicine", "Collaborations", "Communicable Diseases", "Communication", "Communities", "Dendritic Cells", "Development", "Diabetes Mellitus", "Disabled Persons", "Disease", "Engineering", "Ensure", "Environment", "Ethnic group", "Exclusion", "Faculty", "Feedback", "Female", "Financial Support", "Fostering", "Future", "Genetic", "Genomics", "Goals", "Growth", "HIV-associated neurocognitive disorder", "Health", "Homeostasis", "Host Defense", "Hour", "Human", "Image", "Immune system", "Immunity", "Immunology", "Individual", "Infection", "Inflammation", "Inflammatory Bowel Diseases", "Innate Immune System", "International", "Knowledge", "Lead", "Learning", "Location", "Longevity", "Lupus", "Malignant Neoplasms", "Mentors", "Mentorship", "Microbiology", "Microglia", "Mission", "Molecular", "Molecular Genetics", "Multiple Sclerosis", "National Institute of Allergy and Infectious Disease", "Neurologic", "New Hampshire", "Pathologic", "Pathologic Processes", "Pathology", "Phagocytes", "Phagocytosis", "Pharmacology", "Play", "Postdoctoral Fellow", "Research", "Research Personnel", "Resort", "Rheumatoid Arthritis", "Role", "Running", "Science", "Scientist", "Stroke", "Students", "Talents", "Tissues", "Underrepresented Minority", "United States National Institutes of Health", "Woman", "career", "career development", "cell type", "cohort", "community building", "diversity and inclusion", "fly", "graduate student", "improved", "innate immune function", "macrophage", "male", "meetings", "microbial", "microbiota", "migration", "monocyte", "nervous system disorder", "neuroinflammation", "neutrophil", "new therapeutic target", "next generation", "novel", "particle", "pathogen", "peer", "posters", "professor", "programs", "recruit", "role model", "skills", "supportive environment", "symposium", "technological innovation", "therapeutic target", "translational approach" ], "approved": true } }, { "type": "Grant", "id": "10813", "attributes": { "award_id": "1R13HL167550-01", "title": "2023 Nitric Oxide GRC and GRS", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Heart Lung and Blood Institute (NHLBI)" ], "program_reference_codes": [], "program_officials": [ { "id": 23669, "first_name": "Marc F.", "last_name": "Charette", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-02-01", "end_date": "2024-01-31", "award_amount": 15000, "principal_investigator": { "id": 26893, "first_name": "Andrew J", "last_name": "Gow", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "This proposal requests partial support for a meeting on the “Molecular Mechanisms of Nitric Oxide Signaling in Health and Disease” as a Gordon Research Conference (GRC) and Gordon Research Seminar (GRS) to be held in Ventura California from February 12th -17th 2023. The broad and long-term goal of this conference is to bring together the world's leading researchers in this field to foster cross-disciplinary discussions and collaborations. The meeting is designed to enhance our understanding of Nitric Oxide as a regulator of physiological function and as such an important target for control in both health and disease. In particular, we are interested in emphasizing how restoring appropriate Nitric Oxide signaling can alleviate diseases as varied as diabetes, hypertension, asthma, and COVID-19 related pneumonia. The 2023 conference will include a GRS for trainees held immediately prior to and in conjunction with the GRC. The specific aims of this meeting will be to convene over 35 leading experts who will present unpublished data and insights within the field of Nitric Oxide research. The GRC program will be structured into 9 sessions that comprehensively cover the field with sessions focused on cardiovascular performance, molecular mechanisms of signaling, Nitric Oxide generation and detection, and the role of Nitric Oxide in respiratory health. Both basic and translational research will be highlighted, with a major emphasis on physiological signaling and disruptions of this system that can be targeted to improve human health. Afternoon poster sessions will permit all participants to contribute to these topics with the most meritorious abstracts chosen by the conference Chair and Vice-Chair for oral presentations. Every effort will be made to encourage participation by graduate students and postdoctoral fellows in the GRC. In addition, the GRS will be specifically aimed at trainees, allowing them to present their research and interact in a relaxing and extra supportive environment. Every effort will be made to promote gender parity and include racial/ethnic minorities and persons with disabilities. The significance of this application lies in the much needed forum provided by the GRC and GRS to bring together and synergize the members of an international research community working on Nitric Oxide. Nitric Oxide research is unique in that it brings together chemists, environmental scientists, pulmonary and cardiovascular physicians. The Gordon conference on NO which has run since 1995 provides one of the only venues that brings together this diverse group and promotes transformational research ideas. The GRS will have the added value of helping to train and energize the next generation of researchers in the field. The need for greater understanding of how Nitric Oxide is critical to normal human function has only been made more apparent in the recent COVID pandemic. Nitric Oxide based detection and delivery systems are currently in use to not only treat patients, but to improve general health levels and improve resistant to disease. The investigators brought together by this conference have the potential to bring about true transformational change in human health.", "keywords": [ "Address", "Air Pollutants", "Alzheimer&apos", "s Disease", "Asthma", "Athletic", "Award", "Bacteria", "Basic Science", "Biochemistry", "Blood Vessels", "Budgets", "COVID-19 pandemic", "COVID-19 patient", "COVID-19 pneumonia", "California", "Carcinogens", "Cardiopulmonary", "Cardiovascular Diseases", "Cardiovascular system", "Chemistry", "Collaborations", "Communities", "Complex", "Consumption", "Data", "Detection", "Development", "Diabetes Mellitus", "Disabled Persons", "Discipline", "Disease", "Disease Resistance", "Dose", "Endothelium-Dependent Relaxing Factors", "Environment", "Enzymes", "Ethnic group", "Explosion", "Failure", "Fostering", "Functional disorder", "Funding", "Gender", "Generations", "Goals", "Health", "Health Status", "Hemoglobin", "Human", "Human Biology", "Human body", "Hypertension", "Inflammation", "International", "Life", "Lung", "Lung diseases", "Mission", "Molecular", "Nature", "Nitric Oxide", "Nitric Oxide Synthase", "Nitrous Oxide", "Nobel Prize", "Oral", "Organism", "Oxides", "Participant", "Pathology", "Patients", "Performance", "Pharmacology and Toxicology", "Physicians", "Physiological", "Physiology", "Play", "Postdoctoral Fellow", "Preparation", "Production", "Reaction", "Recording of previous events", "Relaxation", "Request for Proposals", "Research", "Research Personnel", "Role", "Running", "Science", "Scientist", "Signal Pathway", "Signal Transduction", "Signaling Molecule", "Source", "Structure", "System", "Therapeutic", "Therapeutic Intervention", "Time", "Training", "Translational Research", "United States National Institutes of Health", "Universities", "Vascular System", "Work", "base", "body system", "design", "ethnic minority", "experience", "graduate student", "human disease", "improved", "inhaled nitric oxide", "insight", "interest", "member", "neonatal pulmonary hypertension", "next generation", "novel", "novel therapeutics", "parity", "posters", "prevent", "professor", "programs", "racial and ethnic", "respiratory health", "skills", "supportive environment", "symposium", "synergism" ], "approved": true } }, { "type": "Grant", "id": "11711", "attributes": { "award_id": "1R13AI179135-01", "title": "2023 Microbial Population Biology Gordon Research Conference and Gordon Research Seminar", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 22573, "first_name": "Barbara L.", "last_name": "Mulach", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-07-01", "end_date": "2023-11-30", "award_amount": 7500, "principal_investigator": { "id": 27581, "first_name": "Vaughn", "last_name": "Cooper", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "The rich diversity of our microbial world influences every aspect of human life. Since 1985 the Microbial Population Biology Gordon Research Conference (GRC) has been the premier international meeting on the evolution and ecology of microbial populations, bringing together up to 200 scientists at the forefront of their disciplines for 5 days of intense interactions. Its long-term objective is to improve our understanding of the ecological and evolutionary forces responsible for this diversity. It is preceded by a 2-day Gordon Research Seminar (GRS) that combines research presentations with mentorship for approximately 75 graduate students and postdoctoral fellows. The cancellation of the 2021 meetings due to the COVID pandemic was particularly unfortunate given the expertise and leadership of our community in studying and communicating the evolution and epidemiology of infectious disease. The goal of the 2023 Microbial Population Biology GRC and GRS is to understand how real microbes interact and evolve in nature, with a special emphasis on pandemics. Presenters will build upon decades of model- system research, often featured at previous conferences in this series, seeking to understand how microbial populations interact at scales from landscapes and oceans to intracellular mutualisms and disease. Three of the ten sessions will focus entirely on epidemics and pandemics, one in animal hosts, one in human hosts, and finally a COVID-19 session with a leading epidemiologist and a medical historian. Health-related themes also run through most of the other sessions (e.g., interactions in polymicrobial infections, vector-borne infections, emerging zoonoses, the evolution of antimicrobial resistance, prospects of phage therapy). We expect the 2023 edition of this conference to be timelier than ever before and more relevant to the mission of NIAID and other Institutes for its focus on microbes relevant to human health, including the origins and dynamics of pandemic infections. Our aims are the following: 1) To advance research of not just microbial population biology but also evolutionary epidemiology and microbiome sciences; 2) To catalyze discussions at the interface of related disciplines that study similar phenomena in different systems; 3) To provide a diverse, inclusive, collaborative environment for researchers to share and discuss their latest research on the ecological and evolutionary dynamics of microbial populations in natural communities, including many associated with humans that cause disease; 4) To promote interactions between established and junior investigators (students, postdoctoral trainees, and junior faculty); and 5) To support an independent, affiliated Gordon Research Seminar (GRS) exclusively for postdoctoral scholars and graduate students to present and discuss their research.", "keywords": [ "Affect", "Animals", "Antibiotic Resistance", "Antimicrobial Resistance", "Bacteriophages", "Biology", "Biotechnology", "COVID-19", "COVID-19 pandemic", "Career Choice", "Career Mobility", "Child Care", "Climate", "Clinic", "Coffee", "Collaborations", "Communicable Diseases", "Communication", "Communities", "Creativeness", "Disabled Persons", "Discipline", "Disease", "Ecology", "Ensure", "Epidemic", "Epidemiologist", "Epidemiology", "Evolution", "Faculty", "Family", "Female", "Food", "Funding", "Goals", "Health", "Health Sciences", "Housing", "Human", "Infection", "Infectious Disease Epidemiology", "International", "Laboratories", "Leadership", "Life", "Location", "Maintenance", "Malignant Neoplasms", "Medical", "Mentorship", "Microbe", "Mission", "Modeling", "Mutation", "National Institute of Allergy and Infectious Disease", "Natural Selections", "Nature", "Oceans", "Participant", "Physicians", "Population", "Population Biology", "Postdoctoral Fellow", "Process", "Recreation", "Research", "Research Personnel", "Running", "Science", "Scientist", "Series", "Social Interaction", "Students", "System", "Technology", "Underrepresented Populations", "Zoonoses", "advanced analytics", "animation", "collaborative environment", "community building", "disorder control", "graduate student", "improved", "innovation", "interest", "meetings", "microbial", "microbial community", "microbiome", "microbiome research", "mutualism", "novel strategies", "pandemic disease", "pathogen", "peer", "posters", "programs", "social", "symposium", "systems research", "vector-borne infection" ], "approved": true } }, { "type": "Grant", "id": "11044", "attributes": { "award_id": "1R13AI174635-01", "title": "2023 Malaria GRC & GRS", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 22573, "first_name": "Barbara L.", "last_name": "Mulach", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-02-10", "end_date": "2024-01-31", "award_amount": 6500, "principal_investigator": { "id": 27016, "first_name": "Terrie Ellen", "last_name": "Taylor", "orcid": null, "emails": "[email protected]", "private_emails": null, "keywords": "[]", "approved": true, "websites": "[]", "desired_collaboration": "", "comments": "", "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "Summary/Abstract The combination of the first approved malaria vaccine, the COVID-19 pandemic and a flattening -- since 2015 - - of malaria morbidity and mortality rates has created an opportunity to reflect and re-imagine. What do we need to do to rein in a parasite that has felled armies, shaped the human genome and continues to evolve to elude new medications? Which new approaches, or more nuanced versions of old approaches, will stymie the insect vector, Anopheles mosquitoes? Can we double down on transmission, both to and from the human host? Ninety percent of the burden of malaria falls on sub-Saharan Africa: what critical capacities are needed there to prevent infection and better manage disease? At the 2023 Malaria Gordon Research Conference (GRC, 28 May – 5 June 2023, Rey Don Jaime Grand Hotel, Caselldefels, Spain), we will gather as a community to learn from a broad array of speakers representing traditional areas of malaria interest and expertise (clinical medicine, entomology, epidemiology, parasitology, vaccines, immunology) and to cross-fertilize with contributions from historians, neuroscientists, communication and implementation experts, neurologists and data scientists. The GRC will be held immediately following a Malaria Gordon Research Seminar (GRS), which targets students, postdoctoral fellows and junior investigators, and in the tradition of Gordon Conferences, both will provide safe and inclusive environments for these younger members of the malaria community to discuss new, unpublished data with established investigators and thought leaders during formal sessions, in front of posters, over coffee, at meals, and whilst recreating outdoors. The meeting will prioritize the participation of investigators from malaria-endemic areas. By including individuals from all career stages and a variety of disciplines, we hope to foster innovation and support new collaborative relationships to capitalize on this pivotal moment in malaria control and eradication.", "keywords": [ "Acceleration", "Address", "Africa South of the Sahara", "Anopheles Genus", "Area", "COVID-19 pandemic", "Characteristics", "Clinical", "Clinical Medicine", "Coffee", "Communication", "Communities", "Country", "Culicidae", "Data", "Data Scientist", "Discipline", "Disease Management", "Drug resistance", "Entomology", "Environment", "Epidemiology", "Face", "Feedback", "Fees", "Fostering", "Hour", "Human", "Human Genome", "Immunology", "Individual", "Infection prevention", "Insect Vectors", "Insecticide Resistance", "Learning", "Link", "Malaria", "Malaria Vaccines", "Molecular", "Morbidity - disease rate", "Neurologist", "Parasites", "Parasitology", "Participant", "Pathogenesis", "Patient-Focused Outcomes", "Pharmaceutical Preparations", "Population", "Postdoctoral Fellow", "Prevention", "Recreation", "Relaxation", "Research", "Research Personnel", "Science", "Scientist", "Series", "Shapes", "Sorting", "Spain", "Students", "Survivors", "Vaccines", "Woman", "Work", "career", "clinical care", "design", "diversity and inclusion", "equity diversity and inclusion", "falls", "graduate student", "implementation science", "improved", "innovation", "interest", "meetings", "member", "mortality", "multidisciplinary", "next generation", "novel strategies", "pandemic disease", "posters", "response", "symposium", "transmission process", "vaccinology" ], "approved": true } }, { "type": "Grant", "id": "11415", "attributes": { "award_id": "1R13HL168969-01", "title": "2023 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Heart Lung and Blood Institute (NHLBI)" ], "program_reference_codes": [], "program_officials": [ { "id": 23738, "first_name": "Sara", "last_name": "Lin", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-05-01", "end_date": "2024-04-30", "award_amount": 45000, "principal_investigator": { "id": 23330, "first_name": "Xin", "last_name": "Sun", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 760, "ror": "https://ror.org/0168r3w48", "name": "University of California, San Diego", "address": "", "city": "", "state": "CA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "Project Summary: The 2023 Lung Development, Injury and Repair Gordon Research Conference (GRC) and associated Gordon Research Seminar (GRS) will be held August 12-18, 2023 in Waterville Valley, NH. The theme for the 2023 Lung GRC is \"Post-COVID Return to Respiratory Health\". The 2023 Lung GRC comes at a critical time, because post-acute COVID-19 syndrome including chronic consequence of severe lung injuries will be coming into focus, heightening our need to understand and combat the dysfunctional repair and remodeling that follows severe injury. According to statistics from the World Health Organization, the global burden of lung disease continues to rise, with >4 million deaths annually worldwide attributed to chronic respiratory diseases, including COPD, asthma, and pulmonary fibrosis. While basic scientific research is making substantial strides forward in understanding molecular, cellular and tissue level mechanisms driving respiratory diseases, translation of these findings toward early detection and effective repair and restoration of lung function in chronic respiratory diseases remains a major barrier. Meeting this challenge requires the integration of knowledge from experts spanning lung development, molecular and cell biology, genomics and epigenomics, physiology, bioengineering, matrix biology as well as physicians and translational experts immersed in the diagnosis and treatment of human disease. Lung GRC/GRS 2023 will bring diverse experts together to disseminate and debate the latest findings in the fields of lung development, injury and repair, and to formulate new ideas, collaborations and approaches that will translate biologic discoveries toward meaningful advances in respiratory medicine. A major emphasis of the Lung GRC and GRS is to strengthen the pipeline of scientists and clinicians focused on lung development, injury and repair. Funds from this R13 will be specifically targeted to promote participation in the conference by women, under-represented minorities and people with disabilities, graduate students, postdoctoral fellows, and early career investigators. The unique attributes of the GRC (open scientific exchange, secluded location to maximize engagement, tradition to share unpublished data, abundant time for discussion) and GRS (close trainee interactions with peers and mentors) provide an opportunity for formal and informal interactions and collaborations that are likely to have significant and sustained impact on the field. The 2023 Lung Development, Injury and Repair GRC/GRS will thus promote accelerated progress in understanding and treating chronic lung diseases, and help to ensure the vitality and growth of a diverse pipeline of clinicians and scientists capable of addressing the growing burden of lung diseases.", "keywords": [ "Acceleration", "Address", "Age", "Asthma", "Automobile Driving", "Back", "Biological", "Biology", "Biomedical Engineering", "Career Mobility", "Cellular biology", "Cessation of life", "Chronic", "Chronic Obstructive Pulmonary Disease", "Chronic lung disease", "Clinical", "Collaborations", "Communities", "Data", "Dedications", "Development", "Diagnosis", "Dimensions", "Disabled Persons", "Dissection", "Early Diagnosis", "Ensure", "Ethnic Origin", "Faculty", "Feedback", "Fostering", "Funding", "Gender", "Genomics", "Geography", "Growth", "Hour", "Injury", "Location", "Long COVID", "Lung", "Lung diseases", "Medicine", "Mentors", "Molecular", "Molecular Biology", "Participant", "Persons", "Physicians", "Physiology", "Population", "Positioning Attribute", "Post-Acute Sequelae of SARS-CoV-2 Infection", "Postdoctoral Fellow", "Pulmonary Fibrosis", "Race", "Research", "Research Personnel", "Respiratory Disease", "SARS-CoV-2 infection", "Scientist", "Senior Scientist", "Structure", "Therapeutic", "Time", "Tissues", "Translating", "Translations", "Underrepresented Minority", "Underrepresented Populations", "Viral", "Woman", "World Health Organization", "career", "chronic respiratory disease", "cohort", "combat", "coronavirus disease", "epigenomics", "experience", "graduate student", "human disease", "improved", "injury and repair", "knowledge integration", "lung development", "lung health", "lung injury", "meetings", "minority scientist", "next generation", "novel", "pandemic potential", "peer", "post-COVID-19", "pulmonary function", "repaired", "respiratory", "respiratory health", "restoration", "severe injury", "statistics", "symposium", "translational scientist" ], "approved": true } }, { "type": "Grant", "id": "11095", "attributes": { "award_id": "1R13EB034601-01", "title": "2023 Liquid Crystals Gordon Research Conference & Gordon Research Seminar", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Biomedical Imaging and Bioengineering (NIBIB)" ], "program_reference_codes": [], "program_officials": [ { "id": 27068, "first_name": "DAVID JOSEPH", "last_name": "Gutekunst", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2023-03-01", "end_date": "2024-02-29", "award_amount": 10000, "principal_investigator": { "id": 23870, "first_name": "Cecilia", "last_name": "Leal", "orcid": null, "emails": "[email protected]", "private_emails": null, "keywords": "[]", "approved": true, "websites": "[]", "desired_collaboration": "", "comments": "", "affiliations": [ { "id": 1040, "ror": "", "name": "UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN", "address": "", "city": "", "state": "IL", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 226, "ror": "https://ror.org/05rad4t93", "name": "Gordon Research Conferences", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "Significance, timeliness and rationale. NIBIB's mission is to transform through engineering the understanding of disease and its prevention, detection, diagnosis, and treatment. Life would not be possible without liquid crystalline (LC) order. The most celebrated example is the unique combination of flexibility and confining ability of cell membranes which is possible because lipids cooperatively aggregate into a lamellar LC phase in water. The phase separation underlying the lipid raft paradigm of plasma membrane organization bears all the hall- marks of inter-LC phase transitions, as does separation in suspensions of amyloidogenic protein fibrils in Alz- heimer's disease. Many viruses, e.g., SARS-CoV-2, are enveloped in a lipid membrane and they may employ LC order for packing their nucleic acid cargo. Non-biological LCs have turned out to be sensitive in detecting and reporting on the presence of pathogens and toxins, making them highly interesting for autonomous bio- /chemosensors. LC formation is thus an integral component of what keeps us healthy and causes disease, and they are emerging as a powerful tool for detecting disease agents. Although this connection is known since long, it has until now been researched only marginally, constituting an under-explored opportunity in addressing soci- etal needs. Today, the international LC research community is undergoing a rebirth, fully embracing these as- pects. Interdisciplinary crossovers where LC science meets biological, life and pharmaceutical sciences, and engineering and materials science, play a groundbreaking role in leveraging the opportunities. Additional impact on the core fields of the NIH-NIBIB mission comes from, e.g., the exploration of LC elastomers in soft actuators or implants in the human body. Objective. The chairs seek support for the Gordon Research Conference (GRC) and Seminar (GRS) on Liquid Crystals 2023:“ From Nature to Transformational Technology through Liquid Crys- tal Science”, Southern New Hampshire University, Manchester, NH, June 24–25 (GRS), June 25-June 30 (GRC), 2023. The joint meetings will bring together US and international researchers at the forefront of today's vibrant LC science, spanning its full breadth and connecting academia, industry and military labs, young and senior, and harnessing every opportunity to promote women and underrepresented minorities as speakers, discussing lead- ers and participants. Approach. 30 prominent speakers have confirmed our invitations to present unpublished cutting-edge research, covering, e.g., LCs in and from nature, LC-self-assembly in colloids and polymers, and in emerging applications. 52% of speakers are female and 37% are non-white. Academic speakers are comple- mented by 2 industry and 2 military research lab speakers. Additionally, 5 speaker slots will be given to excellent young scientists selected from submitted poster abstracts. To further strengthen the voice of young researchers, the GRC is preceded by the GRS, catering only to students and post-docs and providing mentoring and career advice, and during the GRC, young scientists will be given precedence in all scientific discussions.", "keywords": [ "2019-nCoV", "Academia", "Address", "Alzheimer&apos", "s Disease", "Applied Research", "Area", "Basic Science", "Biological", "Biology", "Biosensing Techniques", "Biosensor", "Birth", "Capsid", "Caring", "Cell membrane", "Chemistry", "Collaborations", "Colloids", "Color", "Communities", "Complement 2", "Detection", "Diagnosis", "Disease", "Elastomers", "Engineering", "Environment", "Faculty", "Female", "Fostering", "Future", "Genetic Crossing Over", "Goals", "Hour", "Human body", "Implant", "Industry", "International", "Joints", "Leadership", "Life", "Lipids", "Liquid substance", "Medical", "Membrane Lipids", "Membrane Microdomains", "Mentors", "Military Personnel", "Minority Groups", "Minority Participation", "Mission", "Muscle", "National Institute of Biomedical Imaging and Bioengineering", "Nature", "New Hampshire", "Nucleic Acids", "Oral", "Participant", "Pharmacologic Substance", "Phase", "Phase Transition", "Physics", "Play", "Polymers", "Postdoctoral Fellow", "Prevention", "Proteins", "Reporting", "Research", "Research Personnel", "Robotics", "Role", "Science", "Scientist", "Students", "Suspensions", "Technology", "Toxin", "Underrepresented Minority", "United States National Institutes of Health", "Universities", "Viral", "Virus", "Voice", "Water", "Woman", "active lifestyle", "career", "elastomeric", "empowerment", "experimental study", "flexibility", "liquid crystal", "materials science", "meetings", "pathogen", "peer", "posters", "prevent", "self assembly", "sensor", "social", "symposium", "theories", "tool" ], "approved": true } } ], "meta": { "pagination": { "page": 1392, "pages": 1405, "count": 14046 } } }